Riskpilot← Back to searchSign inGet full accessLana Arif AB
ABActiveOrg 5592911712Särögatan 87Retail sale of pharmaceutical products · NACE 4773Est. 20200 employees
Revenue 2025
SEK 0
EBITDA margin
—
-100% vs 2024
Equity ratio
63.9%
Financial strength
Net profit 2025
SEK 7K
-100% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -10K | -100% |
| Net profit | SEK 7K | -100% |
| Total assets | SEK 3,7M | -9% |
| Equity | SEK 2,4M | +0% |
| Employees | 0 | — |
Legal name
Lana Arif AB
Org number
5592911712
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
16 december 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva apoteks- och hälsokostverksamhet och därmed sammanhörande tjänster och verksamhet. Bolaget skall även bedriva handel med värdepapper.
Address
Särögatan 87
Email
info@hasselbyapotek.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 2 150 | 0 | 2 400 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | 2 148 | −1 | 2 399 | −10 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 2 148 | −1 | 2 399 | −10 |
| Net financials | — | −0 | 14 | 24 |
| Profit before tax | 1 613 | −2 | 1 808 | 14 |
| Tax | −345 | −2 | −377 | −7 |
| Net profit | 1 268 | −3 | 1 431 | 7 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2 710 | 1 811 | 4 073 | 3 706 |
| Equity | 1 293 | 929 | 2 360 | 2 367 |
| Long-term debt | — | — | — | — |
| Short-term debt | 883 | 347 | 573 | 199 |
| Total debt | 883 | 347 | 573 | 199 |
EBITDA margin
-1032600.0%
This company
15.8%
Market median
-6535543% vs market
20222025
Equity ratio
63.9%
This company
38.2%
Market median
+67% vs market
20222025
Return on equity
0.3%
This company
18.4%
Market median
-98% vs market
20222025
Net profit margin
684600.0%
This company
8.1%
Market median
+8451752% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2020-12-16 – 2022-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lana Arif AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peiam Toffik Arif | Deputy Board Member | 0 companies |
| Lana Toffik Arif | Board of Directors | 0 companies |
| Jazia Hajo | Deputy Board Member | 0 companies |